Progress of researches on the antiparasitic activity of antimicrobial peptide LL-37 / 中国血吸虫病防治杂志
Chinese Journal of Schistosomiasis Control
; (6): 98-104, 2024.
Article
em Zh
| WPRIM
| ID: wpr-1013577
Biblioteca responsável:
WPRO
ABSTRACT
Parasitic diseases caused by protozoan and helminth infections are still widespread across the world, notably in tropical and subtropical areas, which threaten the children and adult health. Long-term use of anti-parasitic drugs may result in reduced drug susceptibility and even drug resistance. Antimicrobial peptides have been demonstrated to inhibit parasite growth and development, which has potential antiparasitic values. LL-37, the only human antimicrobial peptide in the cathelicidin family, has been widely investigated. This paper reviews the progress of researches on the antiparasitic activity of LL-37, and discusses the prospects of LL-37 in the research of parasites.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Chinese Journal of Schistosomiasis Control
Ano de publicação:
2024
Tipo de documento:
Article